Lv1
88 积分 2021-05-31 加入
Safety and efficacy of low-dose, cord blood-derived CD19 CAR-NK cells with 4-1BB co-stimulation in refractory systemic lupus erythematosus
1个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
1个月前
已完结
In vivo CAR engineering for immunotherapy
1个月前
已完结
Ultralow-Dose Interleukin 10-Expressing Chimeric Antigen Receptor T Cells in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Nonrandomized Clinical Trial
1个月前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
1个月前
已完结
Identification of Pathogenic PD‐1+CD8+ T Cells for Effective Chimeric Antigen Receptor Therapy in a Murine Model of Sjögren Disease
3个月前
已完结
A novel microprotein L3EMP triggers lung adenocarcinoma progression by catalysing the deubiquitination of SIRT1
3个月前
已完结
IGF2R as a master regulator of acquired EGFR inhibitor resistance and therapeutic target in non-small cell lung cancer
3个月前
已完结
Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases
4个月前
已完结
Hypoxia-responsive CEA-targeted CAR T cells in CEA-positive solid tumors through intraperitoneal or intravenous infusion: a phase 1 trial
6个月前
已完结
皖公网安备34019202002308
